Bruno Manadas

Dr. Bruno Manadas

CNC - Center for Neuroscience and Cell Biology, Coimbra, Portugal
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2005 in Cell Death & Differentiation
Verified
Journal Article
Open access
PDF file
RARamiro De Almeida
Ramiro De Almeida
Bruno ManadasBruno Manadas
Bruno Manadas
CMC V Melo
C V Melo
Joao R GomesJoao R Gomes
Joao R Gomes
CMC S Mendes
C S Mendes
CDCarlos Duarte
Carlos Duarte
Neurotrophins protect neurons against glutamate excitotoxicity, but the signaling mechanisms have not been fully elucidated. We studied the role of the phosphatidylinositol 3-kinase (PI3-K) and Ras/mitogen-activated protein kinase (MAPK) pathways in the protection of cultured hippocampal neurons from glutamate induced apoptotic cell death, characterized by nuclear condensation and activation of caspase-3-like enzymes. Pre-incubation with the neurotrophin brain-derived neurotrophic factor (BDNF), for 24 h, reduced glutamate-evoked apoptotic morphology and caspase-3-like activity, and transiently increased the activity of the PI3-K and of the Ras/MAPK pathways. Inhibition of the PI3-K and of the Ras/MAPK signaling pathways abrogated the protective effect of BDNF against glutamate-induced neuronal death and similar effects were observed upon inhibition of protein synthesis. Moreover, incubation of hippocampal neurons with BDNF, for 24 h, increased Bcl-2 protein levels. The results indicate that the protective effect of BDNF in hippocampal neurons against glutamate toxicity is mediated by the PI3-K and the Ras/MAPK signaling pathways, and involves a long-term change in protein synthesis.

11 October 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
MRMiguel Ribeiro
Miguel Ribeiro
HBHelena C. Brigas
Helena C. Brigas
MTMariana Temido-Ferreira
Mariana Temido-Ferreira
PPPaula A. Pousinha
Paula A. Pousinha
TRTommy Regen
Tommy Regen
JRJulie C. Ribot
Julie C. Ribot
Meningeal γδ T cells are biased toward IL-17 production and control hippocampal synaptic plasticity and short-term memory.

25 May 2016 in Stem Cells and Development
Verified
Journal Article
Closed access
APAna O. Pires
Ana O. Pires
BMBárbara Mendes-Pinheiro
Bárbara Mendes-Pinheiro
Fábio G. TeixeiraFábio G. Teixeira
Fábio G. Teixeira
Sandra AnjoSandra Anjo
Sandra Anjo
SRSilvina Ribeiro-Samy
Silvina Ribeiro-Samy
António SalgadoAntónio Salgado
António Salgado
The use of human mesenchymal stem cells (hMSCs) has emerged as a possible therapeutic strategy for CNS-related conditions. Research in the last decade strongly suggests that MSC-mediated benefits are closely related with their secretome. Studies published in recent years have shown that the secretome of hMSCs isolated from different tissue sources may present significant variation. With this in mind, the present work performed a comparative proteomic-based analysis through mass spectrometry on the secretome of hMSCs derived from bone marrow (BMSCs), adipose tissue (ASCs), and human umbilical cord perivascular cells (HUCPVCs). The results revealed that BMSCs, ASCs, and HUCPVCs differed in their secretion of neurotrophic, neurogenic, axon guidance, axon growth, and neurodifferentiative proteins, as well as proteins with neuroprotective actions against oxidative stress, apoptosis, and excitotoxicity, which have been shown to be involved in several CNS disorder/injury processes. Although important changes were observed within the secretome of the cell populations that were analyzed, all cell populations shared the capability of secreting important neuroregulatory molecules. The difference in their secretion pattern may indicate that their secretome is specific to a condition of the CNS. Nevertheless, the confirmation that the secretome of MSCs isolated from different tissue sources is rich in neuroregulatory molecules represents an important asset not only for the development of future neuroregenerative strategies but also for their use as a therapeutic option for human clinical trials.

1 September 2004 in Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Verified
Journal Article
Closed access
RARamiro De Almeida
Ramiro De Almeida
Bruno ManadasBruno Manadas
Bruno Manadas
ACArsélio P. Carvalho
Arsélio P. Carvalho
CDCarlos Duarte
Carlos Duarte

22 September 2016 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
Fábio G. TeixeiraFábio G. Teixeira
Fábio G. Teixeira
MCMiguel M. Carvalho
Miguel M. Carvalho
KPKrishna M. Panchalingam
Krishna M. Panchalingam
JRJose Rodrigues
Jose Rodrigues
BMBárbara Mendes-Pinheiro
Bárbara Mendes-Pinheiro
António SalgadoAntónio Salgado
António Salgado
Research in the last decade strongly suggests that mesenchymal stem cell (MSC)-mediated therapeutic benefits are mainly due to their secretome, which has been proposed as a possible therapeutic tool for the treatment of Parkinson's disease (PD). Indeed, it has been shown that the MSC secretome increases neurogenesis and cell survival, and has numerous neuroprotective actions under different conditions. Additionally, using dynamic culturing conditions (through computer-controlled bioreactors) can further modulate the MSC secretome, thereby generating a more potent neurotrophic factor cocktail (i.e., conditioned medium). In this study, we have characterized the MSC secretome by proteomic-based analysis, investigating its therapeutic effects on the physiological recovery of a 6-hydroxidopamine (6-OHDA) PD rat model. For this purpose, we injected MSC secretome into the substantia nigra (SNc) and striatum (STR), characterizing the behavioral performance and determining histological parameters for injected animals versus untreated groups. We observed that the secretome potentiated the increase of dopaminergic neurons (i.e., tyrosine hydroxylase-positive cells) and neuronal terminals in the SNc and STR, respectively, thereby supporting the recovery observed in the Parkinsonian rats’ motor performance outcomes (assessed by rotarod and staircase tests). Finally, proteomic characterization of the MSC secretome (through combined mass spectrometry analysis and Bioplex assays) revealed the presence of important neuroregulatory molecules, namely cystatin C, glia-derived nexin, galectin-1, pigment epithelium-derived factor, vascular endothelial growth factor, brain-derived neurotrophic factor, interleukin-6, and glial cell line-derived neurotrophic factor. Overall, we concluded that the use of human MSC secretome alone was able to partially revert the motor phenotype and the neuronal structure of 6-OHDA PD animals. This indicates that the human MSC secretome could represent a novel therapeutic for the treatment of PD.

19 August 2015 in Scientific Reports
Verified
Journal Article
Open access
ASAna Rosa Soares
Ana Rosa Soares
TMTania Martins-Marques
Tania Martins-Marques
TRTeresa M Ribeiro-Rodrigues
Teresa M Ribeiro-Rodrigues
JFJoão Vasco Ferreira
João Vasco Ferreira
SCSteve Catarino
Steve Catarino
HGHenrique Girao
Henrique Girao
Intercellular communication is vital to ensure tissue and organism homeostasis and can occur directly, between neighbour cells via gap junctions (GJ), or indirectly, at longer distances, through extracellular vesicles, including exosomes. Exosomes, as intercellular carriers of messenger molecules, mediate the transfer of biological information between donor and acceptor cells. Although the biological effects of exosomes in target cells have been intensively studied, the mechanisms that govern exosomal uptake are not fully understood. Here, we show that Connexin 43 (Cx43), the most widely expressed GJ protein, is present in exosomes in the form of hexameric channels and, more importantly, that exosomal Cx43 is able to modulate the interaction and transfer of information between exosomes and acceptor cells. This study envisions a new paradigm where Cx43-containing channels mediate the release of exosomal content into cells, which constitutes a novel and unanticipated mechanism to modulate intercellular communication.